BIOVIA's LIMS and ELN software solutions are designed to help laboratories streamline their operations, improve data ...

The 21st century pharmaceutical and biotech sector has ... was brought to the market by Roche in 1963, followed by the introduction of the monoamine oxidase inhibitor (MAOI) class of anti ...

The Global Ophthalmic Viscosurgical Devices market was valued at $705.21 million in 2024 and is projected to grow to $1.65 billion by 2034 , with a CAGR of 8.9% during the forecast period, 2024-2034.

Europe's largest chip company ASML views the emergence of China's DeepSeek as a positive, despite initial market jitters. CEO Christophe Fouquet highlights the benefits of cost-efficient AI models ...

The govt’s plans to set up cancer daycare centres at all district hospitals have been lauded widely, as they are expected to ...